GSK-2330811
GSK-2330811 is a humanized IgG1 antibody that targets Oncostatin M (OSM) . GSK-2330811 has the potential for the study of diffuse cutaneous systemic sclerosis (dcSSc) . The isotype control for GSK-2330811 can refer to Human IgG1 kappa, Isotype Control (HY-P99001) [1].
Product Specifications
UNSPSC
12352203
Target
Interleukin Related
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Purity
98.69
Smiles
[GSK-2330811]
References & Citations
[1]Denton CP, et al. Biological and clinical insights from a randomized phase 2 study of an anti-oncostatin M monoclonal antibody in systemic sclerosis. Rheumatology (Oxford) . 2022 Dec 23;62 (1) :234-242.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
TRC-B556470-1G 1 g
tert-Butyl 4'-Chloro-2'-oxospiro[azetidine-3,3'-indoline]-1-carboxylate
Ask
View Details